Carregant...

Randomized Clinical Trial Of Immunogenicity And Safety Of A Recombinant H1N1/2009 Pandemic Influenza Vaccine Containing Advax™ Polysaccharide Adjuvant

BACKGROUND: Timely vaccine supply is critical during influenza pandemics. A recombinant hemagglutinin (rHA)-based vaccine could overcome production hurdles of egg-based vaccines but has never previously been tested in a real-life pandemic setting. The primary aim was to determine the efficacy of a r...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Gordon, David L., Sajkov, Dimitar, Woodman, Richard J., Honda-Okubo, Yoshikazu, Cox, Manon M.J., Heinzel, Susanne, Petrovsky, Nikolai
Format: Artigo
Idioma:Inglês
Publicat: 2012
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3410954/
https://ncbi.nlm.nih.gov/pubmed/22717330
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.vaccine.2012.06.009
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!